Home›Stock Screener›Anuh Pharma

Anuh Pharma Share Price Today | Stock Price & Anuh Pharma Share Screener

ANUHPHR Pharmaceuticals
Live Share Price NSE
₹84.15
▼ -1.70 (-1.98%)
2026-10-05 00:00:00
Live Share Price BSE
₹84.10
▼ -2.78 (-3.20%)
2026-10-05 00:00:00

As of October 5, 2026, the live Anuh Pharma share price (NSE: ANUHPHR) is ₹84.15 on NSE and ₹84.10 on BSE, down 1.98% from the previous close, with shares trading between ₹83.70 and ₹88.49 in today's trading session, and a 52-week range of ₹67.00–₹96.74. Check Anuh Pharma 52-week for the annual price range and momentum. Use the Anuh Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Anuh Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹784 and net income of ₹44, with EBITDA of ₹72, an operating margin of 9.0% and a profit margin of 5.6%.

Anuh Pharma Market Cap ₹860.42 Cr.
ANUHPHR P/E Ratio (TTM) 19.89
Anuh Pharma P/B Ratio 2.50
EPS (TTM) ₹4.10
Dividend Yield 1.71%
Debt to Equity 0.02
ANUHPHR 52 Week High ₹96.74
Anuh Pharma 52 Week Low ₹67.00
Operating Margin 9.00%
Profit Margin 5.61%
ANUHPHR Revenue (TTM) ₹784.00
EBITDA ₹72.00
Net Income ₹44.00
Total Assets ₹557.00
Total Equity ₹352.00

Anuh Pharma Share Price Chart

Track the current stock price of Anuh Pharma with an interactive chart. Analyse ANUHPHR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Anuh Pharma stock quote in one place.

The quote of ₹84.15 sits between the 52-week low of ₹67.00 and the 52-week high of ₹96.74, and the latest session moved -1.98% from the previous close.

Anuh Pharma Company Profile - Fundamental Screener

Screen Anuh Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ANUHPHR shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE489G01022.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE489G01022

Anuh Pharma Balance Sheet Screener

Screen ANUHPHR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹557, up from ₹507 in 2025.

Latest statistics put total assets at ₹557 and shareholder funds at ₹352, with a leverage ratio of 0.02.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 557 507 446 405 347 333 326 240 209 189
Current Assets 451 376 339 308 259 238 223 152 154 138
Fixed Assets 57 58 49 53 61 71 84 21 17 17

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 2 2 2 2 3 3 2 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 352 326 291 241 214 191 162 165 150 141
Share Capital 50 25 25 25 25 25 13 13 13 13
Reserves & Surplus 302 301 266 216 189 166 150 152 137 128

Anuh Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Anuh Pharma income statement and profit fundamentals. Analyze ANUHPHR quarterly results. Anuh Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹784 and net profit was ₹44, equal to earnings per unit of ₹4.40, at an operating margin of 9%.

In that period expenses were ₹712, interest cost ₹0 and tax ₹17. The next period listed, 2026-March, shows revenue of ₹776 and net profit of ₹41.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 784 776 671 659 534 492 443 311 325 246 214 330 289
Expenses 712 710 601 572 476 440 387 284 291 220 184 290 254

Operating Costs and Margins

EBITDA 72 66 70 87 57 52 55 27 34 25 30 40 35
Operating Profit % 9.00% 8.00% 9.00% 12.00% 10.00% 10.00% 10.00% 7.00% 9.00% 8.00% 11.00% 11.00% 11.00%
Depreciation 11 11 9 9 10 12 15 7 2 2 2 2 3
Interest 0 1 1 0 0 1 2 1 0 0 0 0 0

Profit and Earnings

Profit Before Tax 60 54 61 78 48 39 39 19 32 23 28 38 32
Tax 17 13 14 18 11 9 10 5 9 7 8 12 10
Net Profit 44 41 47 60 36 31 28 14 23 17 20 26 22
EPS 4.40 4.10 9.45 11.98 7.22 6.10 5.67 2.85 9.33 6.59 8.00 10.30 8.78

Anuh Pharma Cash Flow Screener - Liquidity Fundamentals

Screen ANUHPHR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹3, and net cash flow was an outflow of ₹12.

Over the same period, investing activities provided ₹18 and financing activities used ₹26.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -3 37 13 54 29 -19 49 7 2 26
Investing Activities 18 -20 1 -44 -8 52 -77 3 2 -20

Financing and Net Cash

Financing Activities -26 -5 -9 -12 -20 -33 22 -7 -5 -4
Net Cash Flow -12 12 5 -2 2 0 -5 4 -1 2

Anuh Pharma Shareholding Pattern Screener

See Anuh Pharma shareholding pattern with promoter, FII, and DII holdings. Check Anuh Pharma promoter holding and ownership changes for ANUHPHR on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 71.80%, foreign institutions 0.01%, domestic institutions 0.00% and the public 23.49%, spread across 27,484 shareholders.

The shareholder count was 27,484 in 2026-Jun, compared with 27,425 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jul 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 71.80% 71.80% 71.82% 71.82% 69.92% 69.92% 69.92% 69.92%

Institutional Investors

FII Holding 0.01% 0.05% 0.00% 0.00% 0.03% 0.04% 0.04% 0.02%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.49% 23.57% 23.74% 23.86% 25.83% 25.89% 25.92% 26.02%
Other Holding 4.71% 4.59% 4.44% 4.33% 4.23% 4.16% 4.13% 4.04%
Shareholder Count 27,484 27,425 27,889 28,250 26,157 24,257 24,235 24,048

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Anuh Pharma. Anuh Pharma dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹1.50 per unit for 2026-March, a yield of 1.75%, compared with ₹1.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹1.50, ₹1.50 and ₹2.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹1.50 1.75%
2025-March ₹1.50 2.24%
2024-March ₹2.50 3.35%
2023-March ₹2.00 1.63%
2022-March ₹1.75 4.40%
2021-March ₹1.50 3.49%
2020-March ₹2.75 6.09%
2019-March ₹2.75 9.44%
2018-March ₹2.75 8.14%
2017-March ₹2.50 6.39%

Anuh Pharma Stock Index Membership - Nifty & Sensex

See which indices include Anuh Pharma stock. Check ANUHPHR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Anuh Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Anuh Pharma Market Events Screener - Corporate Actions

Get Anuh Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Anuh Pharma stock events that may affect ANUHPHR share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 12, 2026, with a record date of August 12, 2026.

It is followed by Quarterly Result Announcement dated August 7, 2026 and Dividend dated August 5, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-12 2026-08-12 Annual General Meeting NA -2.51%
2026-08-07 2026-08-07 Quarterly Result Announcement NA -0.45%
2026-08-05 2026-08-05 Dividend ₹ 1.50 /share 1.07%
2026-05-20 2026-05-20 Quarterly Result Announcement NA 0.78%
2026-02-06 2026-02-06 Quarterly Result Announcement NA 7.85%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -3.79%
2025-08-22 2025-08-22 Annual General Meeting NA -13.23%
2025-08-14 2025-08-15 Dividend ₹ 1.50 /share -16.76%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -7.61%
2025-07-15 2025-07-15 Bonus 1:1 -5.91%
2025-05-23 2025-05-23 Quarterly Result Announcement NA 17.41%
2025-02-07 2025-02-07 Quarterly Result Announcement NA 5.24%
2024-11-08 2024-11-08 Quarterly Result Announcement NA 5.11%
2024-08-23 2024-08-23 Annual General Meeting NA -12.70%
2024-08-16 2024-08-16 Dividend ₹ 2.50 /share -13.94%

Anuh Pharma Competitors Screener - Peer Stocks Comparison

Screen ANUHPHR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Anuh Pharma Company Announcements - News & Reports Screener

Screen ANUHPHR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 1, 2026.

The next most recent announcements are dated September 18, 2026 and August 19, 2026.

Date Update Actions
2026-10-01 Closure of Trading Window -
2026-09-18 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR) -
2026-08-19 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-14 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-14 Announcement Under Regulation 30 - General Updates -
2026-08-14 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-12 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-07 Announcement Under Regulation 30 (LODR) - Adoption Of Revised Policy Of Related Party Transactions -
2026-08-07 Announcement Under Regulation 30 (LODR) - Intimation Regarding The Request Received For Withdrawal Of Application For Reclassification. -
2026-08-07 Results - Financial Results For June 30 2026 -
2026-08-07 Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/08/2026 -
2026-08-03 Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2026. -
2026-07-18 General Updates -
2026-07-18 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-18 Reg. 34 (1) Annual Report. -
2026-07-18 Shareholder Meeting - Annual General Meeting On Wednesday 12Th August 2026 -
2026-07-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-26 Closure of Trading Window -
2026-06-20 Clarification For Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹84.15, within a 52-week range of ₹67.00 to ₹96.74. The P/E ratio is 19.89 and the P/B ratio is 2.50, with earnings per unit of ₹4.10. Market capitalisation stands at ₹860.42 Cr and the dividend yield is 1.71%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.